Covid-19 Impact on Global Contraceptives Market Size, Status and Forecast 2020-2026

Covid-19 Impact on Global Contraceptives Market Size, Status and Forecast 2020-2026

Table of Contents
1 Study Coverage
1.1 Contraceptives Product Introduction
1.2 Market Segments
1.3 Key Contraceptives Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Contraceptives Market Size Growth Rate by Type
1.4.2 Prolonged Contraception
1.4.3 Short-term Contraception
1.4.4 Emergency Contraception
1.5 Market by Application
1.5.1 Global Contraceptives Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Contraceptives Industry Impact
1.6.1 How the Covid-19 is Affecting the Contraceptives Industry
1.6.1.1 Contraceptives Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Contraceptives Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Contraceptives Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Contraceptives Market Size Estimates and Forecasts
2.1.1 Global Contraceptives Revenue 2015-2026
2.1.2 Global Contraceptives Sales 2015-2026
2.2 Contraceptives Market Size by Region: 2020 Versus 2026
2.2.1 Global Contraceptives Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Contraceptives Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Contraceptives Competitor Landscape by Players
3.1 Contraceptives Sales by Manufacturers
3.1.1 Contraceptives Sales by Manufacturers (2015-2020)
3.1.2 Contraceptives Sales Market Share by Manufacturers (2015-2020)
3.2 Contraceptives Revenue by Manufacturers
3.2.1 Contraceptives Revenue by Manufacturers (2015-2020)
3.2.2 Contraceptives Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Contraceptives Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Contraceptives Revenue in 2019
3.2.5 Global Contraceptives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Contraceptives Price by Manufacturers
3.4 Contraceptives Manufacturing Base Distribution, Product Types
3.4.1 Contraceptives Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Contraceptives Product Type
3.4.3 Date of International Manufacturers Enter into Contraceptives Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Contraceptives Market Size by Type (2015-2020)
4.1.1 Global Contraceptives Sales by Type (2015-2020)
4.1.2 Global Contraceptives Revenue by Type (2015-2020)
4.1.3 Contraceptives Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Contraceptives Market Size Forecast by Type (2021-2026)
4.2.1 Global Contraceptives Sales Forecast by Type (2021-2026)
4.2.2 Global Contraceptives Revenue Forecast by Type (2021-2026)
4.2.3 Contraceptives Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Contraceptives Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Contraceptives Market Size by Application (2015-2020)
5.1.1 Global Contraceptives Sales by Application (2015-2020)
5.1.2 Global Contraceptives Revenue by Application (2015-2020)
5.1.3 Contraceptives Price by Application (2015-2020)
5.2 Contraceptives Market Size Forecast by Application (2021-2026)
5.2.1 Global Contraceptives Sales Forecast by Application (2021-2026)
5.2.2 Global Contraceptives Revenue Forecast by Application (2021-2026)
5.2.3 Global Contraceptives Price Forecast by Application (2021-2026)
6 North America
6.1 North America Contraceptives by Country
6.1.1 North America Contraceptives Sales by Country
6.1.2 North America Contraceptives Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Contraceptives Market Facts & Figures by Type
6.3 North America Contraceptives Market Facts & Figures by Application
7 Europe
7.1 Europe Contraceptives by Country
7.1.1 Europe Contraceptives Sales by Country
7.1.2 Europe Contraceptives Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Contraceptives Market Facts & Figures by Type
7.3 Europe Contraceptives Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Contraceptives by Region
8.1.1 Asia Pacific Contraceptives Sales by Region
8.1.2 Asia Pacific Contraceptives Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Contraceptives Market Facts & Figures by Type
8.3 Asia Pacific Contraceptives Market Facts & Figures by Application
9 Latin America
9.1 Latin America Contraceptives by Country
9.1.1 Latin America Contraceptives Sales by Country
9.1.2 Latin America Contraceptives Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Contraceptives Market Facts & Figures by Type
9.3 Central & South America Contraceptives Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Contraceptives by Country
10.1.1 Middle East and Africa Contraceptives Sales by Country
10.1.2 Middle East and Africa Contraceptives Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Contraceptives Market Facts & Figures by Type
10.3 Middle East and Africa Contraceptives Market Facts & Figures by Application
11 Company Profiles
11.1 Bayer AG
11.1.1 Bayer AG Corporation Information
11.1.2 Bayer AG Description, Business Overview and Total Revenue
11.1.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer AG Contraceptives Products Offered
11.1.5 Bayer AG Recent Development
11.2 Pfizer, Inc
11.2.1 Pfizer, Inc Corporation Information
11.2.2 Pfizer, Inc Description, Business Overview and Total Revenue
11.2.3 Pfizer, Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer, Inc Contraceptives Products Offered
11.2.5 Pfizer, Inc Recent Development
11.3 Teva Pharmaceutical Industries Ltd
11.3.1 Teva Pharmaceutical Industries Ltd Corporation Information
11.3.2 Teva Pharmaceutical Industries Ltd Description, Business Overview and Total Revenue
11.3.3 Teva Pharmaceutical Industries Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Products Offered
11.3.5 Teva Pharmaceutical Industries Ltd Recent Development
11.4 Merck & Co., Inc
11.4.1 Merck & Co., Inc Corporation Information
11.4.2 Merck & Co., Inc Description, Business Overview and Total Revenue
11.4.3 Merck & Co., Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck & Co., Inc Contraceptives Products Offered
11.4.5 Merck & Co., Inc Recent Development
11.5 Actavis, Inc.
11.5.1 Actavis, Inc. Corporation Information
11.5.2 Actavis, Inc. Description, Business Overview and Total Revenue
11.5.3 Actavis, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Actavis, Inc. Contraceptives Products Offered
11.5.5 Actavis, Inc. Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Description, Business Overview and Total Revenue
11.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Johnson & Johnson Contraceptives Products Offered
11.6.5 Johnson & Johnson Recent Development
11.7 Gedeon Richter
11.7.1 Gedeon Richter Corporation Information
11.7.2 Gedeon Richter Description, Business Overview and Total Revenue
11.7.3 Gedeon Richter Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Gedeon Richter Contraceptives Products Offered
11.7.5 Gedeon Richter Recent Development
11.8 Novo Nordisk A/S
11.8.1 Novo Nordisk A/S Corporation Information
11.8.2 Novo Nordisk A/S Description, Business Overview and Total Revenue
11.8.3 Novo Nordisk A/S Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Novo Nordisk A/S Contraceptives Products Offered
11.8.5 Novo Nordisk A/S Recent Development
11.9 ZiZhu
11.9.1 ZiZhu Corporation Information
11.9.2 ZiZhu Description, Business Overview and Total Revenue
11.9.3 ZiZhu Sales, Revenue and Gross Margin (2015-2020)
11.9.4 ZiZhu Contraceptives Products Offered
11.9.5 ZiZhu Recent Development
11.10 Baijingyu
11.10.1 Baijingyu Corporation Information
11.10.2 Baijingyu Description, Business Overview and Total Revenue
11.10.3 Baijingyu Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Baijingyu Contraceptives Products Offered
11.10.5 Baijingyu Recent Development
11.1 Bayer AG
11.1.1 Bayer AG Corporation Information
11.1.2 Bayer AG Description, Business Overview and Total Revenue
11.1.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer AG Contraceptives Products Offered
11.1.5 Bayer AG Recent Development
11.12 Sine
11.12.1 Sine Corporation Information
11.12.2 Sine Description, Business Overview and Total Revenue
11.12.3 Sine Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Sine Products Offered
11.12.5 Sine Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Contraceptives Market Estimates and Projections by Region
12.1.1 Global Contraceptives Sales Forecast by Regions 2021-2026
12.1.2 Global Contraceptives Revenue Forecast by Regions 2021-2026
12.2 North America Contraceptives Market Size Forecast (2021-2026)
12.2.1 North America: Contraceptives Sales Forecast (2021-2026)
12.2.2 North America: Contraceptives Revenue Forecast (2021-2026)
12.2.3 North America: Contraceptives Market Size Forecast by Country (2021-2026)
12.3 Europe Contraceptives Market Size Forecast (2021-2026)
12.3.1 Europe: Contraceptives Sales Forecast (2021-2026)
12.3.2 Europe: Contraceptives Revenue Forecast (2021-2026)
12.3.3 Europe: Contraceptives Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Contraceptives Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Contraceptives Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Contraceptives Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Contraceptives Market Size Forecast by Region (2021-2026)
12.5 Latin America Contraceptives Market Size Forecast (2021-2026)
12.5.1 Latin America: Contraceptives Sales Forecast (2021-2026)
12.5.2 Latin America: Contraceptives Revenue Forecast (2021-2026)
12.5.3 Latin America: Contraceptives Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Contraceptives Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Contraceptives Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Contraceptives Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Contraceptives Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Contraceptives Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Contraceptives Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Contraceptives Market Segments
Table 2. Ranking of Global Top Contraceptives Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Contraceptives Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Prolonged Contraception
Table 5. Major Manufacturers of Short-term Contraception
Table 6. Major Manufacturers of Emergency Contraception
Table 7. COVID-19 Impact Global Market: (Four Contraceptives Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Contraceptives Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Contraceptives Players to Combat Covid-19 Impact
Table 12. Global Contraceptives Market Size Growth Rate by Application 2020-2026 (MT)
Table 13. Global Contraceptives Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 14. Global Contraceptives Sales by Regions 2015-2020 (MT)
Table 15. Global Contraceptives Sales Market Share by Regions (2015-2020)
Table 16. Global Contraceptives Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Contraceptives Sales by Manufacturers (2015-2020) (MT)
Table 18. Global Contraceptives Sales Share by Manufacturers (2015-2020)
Table 19. Global Contraceptives Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Contraceptives by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Contraceptives as of 2019)
Table 21. Contraceptives Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Contraceptives Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Contraceptives Price (2015-2020) (USD/Kg)
Table 24. Contraceptives Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Contraceptives Product Type
Table 26. Date of International Manufacturers Enter into Contraceptives Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Contraceptives Sales by Type (2015-2020) (MT)
Table 29. Global Contraceptives Sales Share by Type (2015-2020)
Table 30. Global Contraceptives Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Contraceptives Revenue Share by Type (2015-2020)
Table 32. Contraceptives Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 33. Global Contraceptives Sales by Application (2015-2020) (MT)
Table 34. Global Contraceptives Sales Share by Application (2015-2020)
Table 35. North America Contraceptives Sales by Country (2015-2020) (MT)
Table 36. North America Contraceptives Sales Market Share by Country (2015-2020)
Table 37. North America Contraceptives Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Contraceptives Revenue Market Share by Country (2015-2020)
Table 39. North America Contraceptives Sales by Type (2015-2020) (MT)
Table 40. North America Contraceptives Sales Market Share by Type (2015-2020)
Table 41. North America Contraceptives Sales by Application (2015-2020) (MT)
Table 42. North America Contraceptives Sales Market Share by Application (2015-2020)
Table 43. Europe Contraceptives Sales by Country (2015-2020) (MT)
Table 44. Europe Contraceptives Sales Market Share by Country (2015-2020)
Table 45. Europe Contraceptives Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Contraceptives Revenue Market Share by Country (2015-2020)
Table 47. Europe Contraceptives Sales by Type (2015-2020) (MT)
Table 48. Europe Contraceptives Sales Market Share by Type (2015-2020)
Table 49. Europe Contraceptives Sales by Application (2015-2020) (MT)
Table 50. Europe Contraceptives Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Contraceptives Sales by Region (2015-2020) (MT)
Table 52. Asia Pacific Contraceptives Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Contraceptives Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Contraceptives Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Contraceptives Sales by Type (2015-2020) (MT)
Table 56. Asia Pacific Contraceptives Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Contraceptives Sales by Application (2015-2020) (MT)
Table 58. Asia Pacific Contraceptives Sales Market Share by Application (2015-2020)
Table 59. Latin America Contraceptives Sales by Country (2015-2020) (MT)
Table 60. Latin America Contraceptives Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Contraceptives Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Contraceptives Revenue Market Share by Country (2015-2020)
Table 63. Latin America Contraceptives Sales by Type (2015-2020) (MT)
Table 64. Latin America Contraceptives Sales Market Share by Type (2015-2020)
Table 65. Latin America Contraceptives Sales by Application (2015-2020) (MT)
Table 66. Latin America Contraceptives Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Contraceptives Sales by Country (2015-2020) (MT)
Table 68. Middle East and Africa Contraceptives Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Contraceptives Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Contraceptives Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Contraceptives Sales by Type (2015-2020) (MT)
Table 72. Middle East and Africa Contraceptives Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Contraceptives Sales by Application (2015-2020) (MT)
Table 74. Middle East and Africa Contraceptives Sales Market Share by Application (2015-2020)
Table 75. Bayer AG Corporation Information
Table 76. Bayer AG Description and Major Businesses
Table 77. Bayer AG Contraceptives Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 78. Bayer AG Product
Table 79. Bayer AG Recent Development
Table 80. Pfizer, Inc Corporation Information
Table 81. Pfizer, Inc Description and Major Businesses
Table 82. Pfizer, Inc Contraceptives Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Pfizer, Inc Product
Table 84. Pfizer, Inc Recent Development
Table 85. Teva Pharmaceutical Industries Ltd Corporation Information
Table 86. Teva Pharmaceutical Industries Ltd Description and Major Businesses
Table 87. Teva Pharmaceutical Industries Ltd Contraceptives Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Teva Pharmaceutical Industries Ltd Product
Table 89. Teva Pharmaceutical Industries Ltd Recent Development
Table 90. Merck & Co., Inc Corporation Information
Table 91. Merck & Co., Inc Description and Major Businesses
Table 92. Merck & Co., Inc Contraceptives Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Merck & Co., Inc Product
Table 94. Merck & Co., Inc Recent Development
Table 95. Actavis, Inc. Corporation Information
Table 96. Actavis, Inc. Description and Major Businesses
Table 97. Actavis, Inc. Contraceptives Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Actavis, Inc. Product
Table 99. Actavis, Inc. Recent Development
Table 100. Johnson & Johnson Corporation Information
Table 101. Johnson & Johnson Description and Major Businesses
Table 102. Johnson & Johnson Contraceptives Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Johnson & Johnson Product
Table 104. Johnson & Johnson Recent Development
Table 105. Gedeon Richter Corporation Information
Table 106. Gedeon Richter Description and Major Businesses
Table 107. Gedeon Richter Contraceptives Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Gedeon Richter Product
Table 109. Gedeon Richter Recent Development
Table 110. Novo Nordisk A/S Corporation Information
Table 111. Novo Nordisk A/S Description and Major Businesses
Table 112. Novo Nordisk A/S Contraceptives Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Novo Nordisk A/S Product
Table 114. Novo Nordisk A/S Recent Development
Table 115. ZiZhu Corporation Information
Table 116. ZiZhu Description and Major Businesses
Table 117. ZiZhu Contraceptives Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 118. ZiZhu Product
Table 119. ZiZhu Recent Development
Table 120. Baijingyu Corporation Information
Table 121. Baijingyu Description and Major Businesses
Table 122. Baijingyu Contraceptives Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 123. Baijingyu Product
Table 124. Baijingyu Recent Development
Table 125. Huazhong Corporation Information
Table 126. Huazhong Description and Major Businesses
Table 127. Huazhong Contraceptives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 128. Huazhong Product
Table 129. Huazhong Recent Development
Table 130. Sine Corporation Information
Table 131. Sine Description and Major Businesses
Table 132. Sine Contraceptives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 133. Sine Product
Table 134. Sine Recent Development
Table 135. Global Contraceptives Sales Forecast by Regions (2021-2026) (MT)
Table 136. Global Contraceptives Sales Market Share Forecast by Regions (2021-2026)
Table 137. Global Contraceptives Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 138. Global Contraceptives Revenue Market Share Forecast by Regions (2021-2026)
Table 139. North America: Contraceptives Sales Forecast by Country (2021-2026) (MT)
Table 140. North America: Contraceptives Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Europe: Contraceptives Sales Forecast by Country (2021-2026) (MT)
Table 142. Europe: Contraceptives Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Asia Pacific: Contraceptives Sales Forecast by Region (2021-2026) (MT)
Table 144. Asia Pacific: Contraceptives Revenue Forecast by Region (2021-2026) (US$ Million)
Table 145. Latin America: Contraceptives Sales Forecast by Country (2021-2026) (MT)
Table 146. Latin America: Contraceptives Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Middle East and Africa: Contraceptives Sales Forecast by Country (2021-2026) (MT)
Table 148. Middle East and Africa: Contraceptives Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key Contraceptives Players
Table 153. Contraceptives Customers List
Table 154. Contraceptives Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Contraceptives Product Picture
Figure 2. Global Contraceptives Sales Market Share by Type in 2020 & 2026
Figure 3. Prolonged Contraception Product Picture
Figure 4. Short-term Contraception Product Picture
Figure 5. Emergency Contraception Product Picture
Figure 6. Global Contraceptives Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital Pharmacies
Figure 8. Retail Pharmacies
Figure 9. Online Pharmacies
Figure 10. Others
Figure 11. Contraceptives Report Years Considered
Figure 12. Global Contraceptives Market Size 2015-2026 (US$ Million)
Figure 13. Global Contraceptives Sales 2015-2026 (MT)
Figure 14. Global Contraceptives Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Contraceptives Sales Market Share by Region (2015-2020)
Figure 16. Global Contraceptives Sales Market Share by Region in 2019
Figure 17. Global Contraceptives Revenue Market Share by Region (2015-2020)
Figure 18. Global Contraceptives Revenue Market Share by Region in 2019
Figure 19. Global Contraceptives Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Contraceptives Revenue in 2019
Figure 21. Contraceptives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Contraceptives Sales Market Share by Type (2015-2020)
Figure 23. Global Contraceptives Sales Market Share by Type in 2019
Figure 24. Global Contraceptives Revenue Market Share by Type (2015-2020)
Figure 25. Global Contraceptives Revenue Market Share by Type in 2019
Figure 26. Global Contraceptives Market Share by Price Range (2015-2020)
Figure 27. Global Contraceptives Sales Market Share by Application (2015-2020)
Figure 28. Global Contraceptives Sales Market Share by Application in 2019
Figure 29. Global Contraceptives Revenue Market Share by Application (2015-2020)
Figure 30. Global Contraceptives Revenue Market Share by Application in 2019
Figure 31. North America Contraceptives Sales Growth Rate 2015-2020 (MT)
Figure 32. North America Contraceptives Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Contraceptives Sales Market Share by Country in 2019
Figure 34. North America Contraceptives Revenue Market Share by Country in 2019
Figure 35. U.S. Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 36. U.S. Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 38. Canada Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Contraceptives Market Share by Type in 2019
Figure 40. North America Contraceptives Market Share by Application in 2019
Figure 41. Europe Contraceptives Sales Growth Rate 2015-2020 (MT)
Figure 42. Europe Contraceptives Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Contraceptives Sales Market Share by Country in 2019
Figure 44. Europe Contraceptives Revenue Market Share by Country in 2019
Figure 45. Germany Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 46. Germany Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 48. France Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 50. U.K. Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 52. Italy Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 54. Russia Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Contraceptives Market Share by Type in 2019
Figure 56. Europe Contraceptives Market Share by Application in 2019
Figure 57. Asia Pacific Contraceptives Sales Growth Rate 2015-2020 (MT)
Figure 58. Asia Pacific Contraceptives Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Contraceptives Sales Market Share by Region in 2019
Figure 60. Asia Pacific Contraceptives Revenue Market Share by Region in 2019
Figure 61. China Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 62. China Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 64. Japan Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 66. South Korea Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 68. India Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 70. Australia Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 72. Taiwan Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 74. Indonesia Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 76. Thailand Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 78. Malaysia Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 80. Philippines Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 82. Vietnam Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Contraceptives Market Share by Type in 2019
Figure 84. Asia Pacific Contraceptives Market Share by Application in 2019
Figure 85. Latin America Contraceptives Sales Growth Rate 2015-2020 (MT)
Figure 86. Latin America Contraceptives Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Contraceptives Sales Market Share by Country in 2019
Figure 88. Latin America Contraceptives Revenue Market Share by Country in 2019
Figure 89. Mexico Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 90. Mexico Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 92. Brazil Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 94. Argentina Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Contraceptives Market Share by Type in 2019
Figure 96. Latin America Contraceptives Market Share by Application in 2019
Figure 97. Middle East and Africa Contraceptives Sales Growth Rate 2015-2020 (MT)
Figure 98. Middle East and Africa Contraceptives Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Contraceptives Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Contraceptives Revenue Market Share by Country in 2019
Figure 101. Turkey Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 102. Turkey Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 104. Saudi Arabia Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. UAE Contraceptives Sales Growth Rate (2015-2020) (MT)
Figure 106. UAE Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Contraceptives Market Share by Type in 2019
Figure 108. Middle East and Africa Contraceptives Market Share by Application in 2019
Figure 109. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Pfizer, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Teva Pharmaceutical Industries Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Merck & Co., Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Actavis, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Gedeon Richter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Novo Nordisk A/S Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. ZiZhu Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Baijingyu Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Huazhong Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Sine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. North America Contraceptives Sales Growth Rate Forecast (2021-2026) (MT)
Figure 122. North America Contraceptives Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Europe Contraceptives Sales Growth Rate Forecast (2021-2026) (MT)
Figure 124. Europe Contraceptives Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Asia Pacific Contraceptives Sales Growth Rate Forecast (2021-2026) (MT)
Figure 126. Asia Pacific Contraceptives Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Latin America Contraceptives Sales Growth Rate Forecast (2021-2026) (MT)
Figure 128. Latin America Contraceptives Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Middle East and Africa Contraceptives Sales Growth Rate Forecast (2021-2026) (MT)
Figure 130. Middle East and Africa Contraceptives Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Porter's Five Forces Analysis
Figure 132. Channels of Distribution
Figure 133. Distributors Profiles
Figure 134. Bottom-up and Top-down Approaches for T

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119

According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......

Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......

Global Contraceptives Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141

According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period. The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......

Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108

According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......

Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 99

Market Overview of Global Menopausal Hot Flashes market: According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......

Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 139

Report Overview: This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......

Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122

Report Overview: The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......

Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 108

Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years. Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......

Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Tocolysis Drugs market: According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs